Trial Profile
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Lafutidine (Primary) ; Aspirin; Loxoprofen
- Indications NSAID-induced gastric damage
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.